Skip to the page

Data / Form D filings / S4 Medical Corp.

S4 Medical Corp.: Form D filings

S4 Medical Corp., a biotechnology company in Chagrin Falls, OH, filed 4 Form D notices with the SEC between 2021 and 2023. The latest, on July 7, 2023, reports $5.8 million sold of a $7.8 million offering to 11 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
34 SOUTH MAIN, SUITE 200, Chagrin Falls, OH, 44022
Phone
(440) 279-8091
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1852724

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 7, 2023New notice$7,762,026$5,762,025$2,000,00111Jun 23, 2023sec.gov
Mar 29, 2023New notice$850,000$745,844$104,15610Mar 14, 2023sec.gov
Apr 8, 2021Amendment$3,474,985$3,024,985$450,00011Mar 10, 2021sec.gov
Mar 25, 2021New notice$3,474,985$2,999,985$475,00010Mar 10, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Bill BaumelDirector
William FullerExecutive Officer, Director
Roy TanakaDirector
Emile DaoudExecutive Officer, Director
Anila LingamneniDirector

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Jul 3, 2023 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what S4 Medical Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.